Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last [Seeking Alpha]
Organon & Co. (OGN)
Company Research
Source: Seeking Alpha
The company's focus on developing new revenue streams in Women's Health and Biosimilars is starting to show promise. Organon's established brands division is still performing well, but the company expects flat performance in 2024 as it looks to drive growth in other areas. Organon has massive debt of ~$8bn after being spun out by Merck & Co, but management executed well last quarter and the company can have a good year in 2024. Investment Overview Organon & Co. NYSE: OGN ) shareholders have been desperately hoping for some good news from management, after a tough set of Q3 earnings , which I covered in a post for Seeking Alpha in early November, sent the company's share price plummeting to lows of ~$11. Yesterday, OGN shares climbed to a ~6-month high of $18 after an upbeat set of Q4 earnings Organon is the result of Pharma giant Merck's ( MRK ) spinout of its Women's Health, Biosimilars, and Established Brands division into a separate entity, which began trading in June 20
Show less
Read more
Impact Snapshot
Event Time:
OGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OGN alerts
High impacting Organon & Co. news events
Weekly update
A roundup of the hottest topics
OGN
News
- Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $20.00. They now have a "neutral" rating on the stock.MarketBeat
- Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- What Makes Organon (OGN) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Organon Reports Results for the First Quarter Ended March 31, 2024Business Wire
- Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store? [Yahoo! Finance]Yahoo! Finance
OGN
Earnings
- 5/2/24 - Beat
OGN
Sec Filings
- 5/3/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/25/24 - Form ARS
- OGN's page on the SEC website